clinical evaluation of a vegf inhibitor in patients with livermetastases from solid tumours
TRANSCRIPT
-
8/7/2019 Clinical Evaluation of a VEGF Inhibitor in Patients with Livermetastases from Solid Tumours
1/8
@ICZBJ 6 L[[DHO@JOS
SDSBJ) SI]DK7 ]UI]I[JC [SULSJHT FIU KBDODKLB JVLBZLSDIO IF
]SN)WN" L VJHF DOADEDSIU DO ]LSDJOS[ XDSA BDVJU
@JSL[SL[J[ FUI@ [IBDC SZ@IZU[
[ZE@DSSJC ET 7 LCJU[A/[/Z/
ELSKA 7 5==4 - 5=
-
8/7/2019 Clinical Evaluation of a VEGF Inhibitor in Patients with Livermetastases from Solid Tumours
2/8
ELKNHUIZOC DOFIU@LSDIO
Klokjr ds io if taj cjlcbdjst if lbb cdsjlsjs loc als oiw ejki`j `irj ki``io/ Dt ds
taj uokiotribblebj loc uoirhlodzjc rlpdc hriwta if kjbbs do taj eicy" `ist td`j irdhdoltjcfri` l sdohbj kjbb hjojtdk `utltdio/ Saj rlpdcby hriwdoh `lss if tdssuj ds rjfjrrjc ls tu`iur/
Saj prjvlbjokj if klokjr als ejjo dokrjlsdoh jlka yjlr loc dt ds taj bjlcdoh klusj if cjlta if
pjipbj do `loy cjvjbipjc kiuotrdjs/ Klokjr klo prihrjss doti loy plrt" loy irhlo if taj
eicy/ Jvjo taiuha ki`pbjtj kurj if klokjr ds oit pissdebj" tajrj lrj `loy trjlt`jots
lvldblebj ticly wadka lrj ajbpfub do lbbjvdltdoh taj dotjosdty if taj cdsjlsj ti taj `lxd`u`
loc ti prjvjot taj prihrjssdio if taj cdsjlsj/ Aiwjvjr tajrj lrj si`j `dsejbdjvjs l`ioh
`ist pjipbj talt klokjr ds lo dokurlebj cdsjlsj loc taj pltdjot als ti ejlr taj d``josj pldo
tariuhaiut ads bdfj/ Sajrj lrj `loy rjsjlrkajs hidoh io wirbcwdcj do taj purpisj if fdocdoh
iut l ejttjr trjlt`jot loc si`jtd`js fir taj ki`pbjtj jrlcdkltdio if taj cdsjlsj/
]jrtldodoh ti taj `jkalods` loc prihrjssdio if taj klokjr" taj prikjss if
lohdihjojsds ds vjry d`pirtlot/ Lohdihjojsds ds taj prikjss if cjvjbip`jot if ojw ebiic
vjssjbs fri` taj prj jxdstdoh iojs !Oltdiolb Klokjr Dostdtutj 5==:$/ Sajsj ojw vjssjbs suppby
outrdjots loc ixyhjo ti taj tu`iur kjbbs" lbbiwdoh taj rlpdc hriwta/ Doadedtdio if
lohdihjojsds do loc lriuoc taj rlpdcby hriwdoh kjbbs kiubc jffjktdvjby prjvjot taj
prihrjssdio if klokjr ti taj itajr sdtjs/ Sicly klokjr rjsjlrkajs kiokjotrltj `irj io
lohdihjojsds doadedtdio loc tajrj lrj `loy lohdihjojsds doadedtdoh cruhs uocjr kbdodklb
jvlbultdio do rjkjot yjlrs !OKD 5==:$/
Hriwta flktirs lrj taj d`pirtlot pri`itjrs if lohdihjojsds loc l`ioh taj` vlskublr
jocitajbdlb hriwta flktirs !VJHF$ lrj taj njy pblyjrs/ VJHF alvj vdtlb ribj do vlskublr
pjr`jledbdty loc ojivlskublrdsltdio ![klppltdkkd FL jtl b 5==5" Fjrrlrl O/ Jt lb
-
8/7/2019 Clinical Evaluation of a VEGF Inhibitor in Patients with Livermetastases from Solid Tumours
3/8
Itajr Dokbusdio Krdtjrdl7
Jstd`ltjc bdfj jxpjktloky7 ; `iotas Lesibutj Ojutripadb Kiuot !LOK$7
-
8/7/2019 Clinical Evaluation of a VEGF Inhibitor in Patients with Livermetastases from Solid Tumours
4/8
@IVDOH SI SAJ OJQS ]AL[JSAJ ]UI]I[JC [SULSJHT
Saj pisdtdvj iutki`j if palsj D stucy ipjojc l wly fir ]SN)WN" taj rjspjktjc cruh
do taj puebdsajc stucy ti `ivj ti taj ojxt palsj if cjvjbip`jot/ Saj pripisjc strltjhy ds ti
kiocukt l palsj DDD kbdodklb jvlbultdio ti lssjss taj slfjty loc jffdklky if ]SN)WN ki`plrjc
wdta l stloclrc kaj`itajrlpy !: fbuiriurlkdb)ixlkdpbltdo)bjunivirdo ^FIBFIQ 3P$/ Sads
strltjhy ds elsjc io taj ojw trjoc do iokibihy talt usjs vlrdius lotdlohdihjodk suestlokjs"
jspjkdlbby taj VJHF doadedtirs fir taj trjlt`jot if vlrdius typjs if klokjrs/ Saj palsj D
jvlbultdio if ]SN)WN do pltdjots wdta bdvjr `jtlstlsjs rjki``jocjc l cisj if
-
8/7/2019 Clinical Evaluation of a VEGF Inhibitor in Patients with Livermetastases from Solid Tumours
5/8
ULSDIOLBJ IF SAJ ]UI]I[JC [SZCT
Saj pisdtdvj iutki`j if taj palsj D stucy urhjc ojjc if kiocuktdoh l palsj DDD stucy
wadka jvlbultjs slfjty loc jffdklky if ]SN)WN do blrhj pipubltdio/ Lohdihjojsds ds ki``iodo klrkdoi`l loc lohdihjodk cruhs wdbb ej `uka jffjktdvj do `ist typjs if klokjrs loc si
palsj DD klo ej sndppjc/ Lotdlohdihjodk suestlokjs lrj wdcjby ejjo usjc do `loy iokibihy
trdlbs do rjkjot yjlrs loc dt ds fiuoc ti ej jffjktdvj do `loy klsjs/ Saj pripisjc strltjhy ds
elsjc io tads dofir`ltdio loc cltl/ ]alsj DDD kbdodklb stucdjs usulbby ki`plrj taj
jxpjrd`jotlb cruh ti l stloclrc cruh/ Do taj pripisjc stucy ]SN)WN wdbb ej ki`plrjc wdta
FIBFIQ 3" l stloclrc kaj`itajrlpdk suestlokj/ Kaj`itajrlpy ds taj stloclrc trjlt`jot
iptdio fir `loy klokjrs" dokbucdoh kibirjktlb klokjr wdta bdvjr `jtlstlsjs/ Saj prikjss if
rloci`dzltdio wdbb ajbp ti lvidc `loy sjbjktdio ir lbbikltdio edls loc ajbp ti rloci`by
lssdho taj pltdjots ti jlka trjlt`jot hriups/
Saj stucy wdbb ej `ubtdkjotrdk loc wdbb alvj sdtjs do cjvjbipjc ls wjbb ls cjvjbipdoh
kiuotrdjs/ Sajrj wiubc ej `irj sdtjs do taj cjvjbipjc kiuotrdjs sdokj taj prjvlbjokj if
klokjr als ejjo dokrjlsdoh do `loy cjvjbipjc kiuotrdjs do rjkjot yjlrs/ Saj cisj if ]SN)WN
wdbb ej
-
8/7/2019 Clinical Evaluation of a VEGF Inhibitor in Patients with Livermetastases from Solid Tumours
6/8
]rd`lry Iutki`j Lssjss`jot7
]rihrjssdio frjj survdvlb" wdta l `dod`u` if
-
8/7/2019 Clinical Evaluation of a VEGF Inhibitor in Patients with Livermetastases from Solid Tumours
7/8
@jlsurj`jot if Jffdklky7
Lbb taj pltdjots wdbb ej d`lhjc wdta Cyol`dk Kiotrlst Joalokjc @lhojtdk Ujsiolokj
D`lhdoh !CKJ-@UD$ ti cjtjkt taj tu`iur ebiic suppby/ Vlskublrdty loc pjr`jledbdty if
tu`iur kjbbs wdbb ej lssjssjc ey klbkubltdoh taj edcdrjktdiolb trlosfjr kiostlot !Nd$/
[lfjty Lssjss`jots7
Lcvjrsj cruh rjlktdios loc sjrdius lcvjrsj jvjots wiubc ej taj plrl`jtjrs if slfjty
`jlsurjs/ Lbb suka jvjots wdbb ej rjpirtjc ti spiosirs" tajo ti jtadks ki``dttjj" fibbiwjc ey
rjhubltiry lutairdtdjs wdtado taj td`j skajcubjs hdvjo ey taj rjhubltiry eicdjs/
[tltdstdklb Lolbysds7
Kad squlrj tjst wdbb ej taj `lgir tjst usjc fir taj stltdstdklb lolbysds purpisj wdta l
prieledbdty !p$ if 2=/=:/ Saj survdvlb rltj !ivjrlbb loc prihrjssdio frjj$ if pltdjots wdbb ej
`jlsurjc usdoh Nlpblo-@jdjr tjst do eita lr`s/ [l`pbj sdzj wdbb ej klbkubltjc wdta l :=*
sdhodfdklokj bjvjb loc 4=* piwjr wdta rjspjkt ti taj prjvlbjokj rltj/
Jtadklb Kiosdcjrltdios7
]rdir ti taj ki``jokj`jot if taj stucy" ojkjsslry lpprivlb fir lbb ciku`jots pritikibs"
[I]s" dofir`jc kiosjot ciku`jots wdbb ej kibbjktjc fri` taj jtadks ki``dttjj/ Sajy wdbb
lbsi ej dofir`jc wdta lbb sjrdius lcvjrsj jvjots ikkurrdoh curdoh taj stucy io td`j/ Jotdrj
stucy wdbb ej rjvdjwjc ey DJK ir DUE/ Lbb taj lspjkts if taj stucy wdbb ej jxpbldojc wjbb do
cjtldb ti jlka pltdjot curdoh taj dofir`jc kiosjot prikjss loc sdhojc cltjc wrdttjo kiosjot
wdbb ej tlnjo fri` taj`/ Lbb taj cjtldbs if taj suegjkts wdbb ej njpt kiofdcjotdlbby tariuhaiut
taj stucy/ Saj jotdrj stucy wdbb ej kiocuktjc do lkkirclokj wdta lbb taj kiokjrojc rjhubltdios
loc hudcjbdojs ti josurj qulbdty rjsjlrka/
-
8/7/2019 Clinical Evaluation of a VEGF Inhibitor in Patients with Livermetastases from Solid Tumours
8/8
UJFJUJOKJ[